- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02561624
Hati Salama (Secure Voucher)
April 12, 2016 updated by: Dr. Karen Yeates, Queen's University
Expanding the Successful E-voucher System to Improve Malaria Prevention and Fight New Global Health Threats Through Innovative Health Partnerships and Mobile Phone Technology in Tanzania
The use of long-lasting insecticide treated nets (LLINs) is shown to reduce malaria prevalence.
The Tanzania Net Voucher Scheme has been an active component of bed net distribution to pregnant women in Tanzania since 2004.
The transition from paper vouchers to electronic vouchers in this program has increased efficiency and the ability to track and distribute nets since 2007.
Although the program has been successful, to date, electronic voucher redemption varies widely across the country and it has not been clearly established as to what barriers exist for women who receive electronic vouchers in the program.
This cluster-randomized trial was designed to examine perceived barriers to electronic voucher redemption among pregnant women and to evaluate if educational and personalized text messages around electronic voucher redemption and bed net usage will increase electronic voucher redemption when directed at pregnant women who receive electronic vouchers in the currently existing program.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Study Type
Interventional
Enrollment (Actual)
5219
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
-
Moshi, Tanzania
- Pamoja Tunawez
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years to 50 years (Adult)
Accepts Healthy Volunteers
Yes
Genders Eligible for Study
Female
Description
Inclusion Criteria:
- Pregnant women capable of providing informed consent
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Prevention
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Triple
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: Intervention
Use of behaviour change communication via text messages to pregnant women receiving an electronic voucher for long lasting insecticide treated nets redemption through antenatal clinics.
|
|
No Intervention: Control
Control group receives no behaviour change communication via text message, but receives an electronic voucher for long lasting insecticide treated nets redemption through antenatal clinics.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Increased uptake of long-lasting insecticide treated nets from retailers using an electronic voucher through text messaging.
Time Frame: 12 weeks
|
The outcome measure will be assessed by LLIN evoucher redemption.
|
12 weeks
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Collaborators
Investigators
- Principal Investigator: Karen Yeates, MD, Queen's University
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
July 1, 2015
Primary Completion (Actual)
January 1, 2016
Study Completion (Actual)
January 1, 2016
Study Registration Dates
First Submitted
July 20, 2015
First Submitted That Met QC Criteria
September 25, 2015
First Posted (Estimate)
September 28, 2015
Study Record Updates
Last Update Posted (Estimate)
April 13, 2016
Last Update Submitted That Met QC Criteria
April 12, 2016
Last Verified
April 1, 2016
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- DMED-1712-14
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Malaria
-
University of California, San FranciscoCenters for Disease Control and Prevention; University of Massachusetts, Amherst and other collaboratorsRecruitingPlasmodium Falciparum Malaria | Plasmodium Vivax MalariaLao People's Democratic Republic
-
University of OxfordWellcome Trust; Ministry of public Health AfghanistanCompletedVivax Malaria | Uncomplicated Falciparum MalariaAfghanistan
-
Menzies School of Health ResearchInternational Centre for Diarrhoeal Disease Research, Bangladesh; Addis Ababa... and other collaboratorsCompletedMalaria | Vivax Malaria | Falciparum MalariaEthiopia, Bangladesh, Indonesia
-
Medicines for Malaria VentureAsociacion Civil Selva AmazonicaCompletedPlasmodium Falciparum Malaria | Plasmodium Vivax MalariaPeru
-
Gadjah Mada UniversityMenzies School of Health Research; Eijkman Institute for Molecular Biology; Timika...Completed
-
London School of Hygiene and Tropical MedicineWorld Health Organization; United Nations High Commissioner for Refugees; HealthNet... and other collaboratorsCompletedMalaria | Vivax Malaria | Falciparum MalariaPakistan
-
Menzies School of Health ResearchNational Health and Medical Research Council, Australia; Wellcome Trust; National...CompletedVivax Malaria | Falciparum MalariaIndonesia
-
Menzies School of Health ResearchNational Health and Medical Research Council, Australia; Wellcome Trust; National...CompletedVivax Malaria | Falciparum MalariaIndonesia
-
University of IbadanShin Poong Pharm Co Ltd 161 yoksam-ro, Gangnam-Gu Seoul 135-925, Korea; Institute...CompletedPlasmodium Falciparum Malaria | Uncomplicated Malaria | Malaria FeverNigeria
-
Research Institute for Tropical Medicine, PhilippinesWorld Health OrganizationCompletedTES of Artemether-lumefantrine for Pf and Chloroquine for Pv in the Philippines From 2013-2014 (TES)Malaria | Vivax Malaria | Falciparum Malaria | Malaria Recrudescence
Clinical Trials on Behaviour change communication via text message
-
India Diabetes Research Foundation & Dr. A. Ramachandran...Completed
-
Jimma UniversityRecruitingKnowledge, Attitudes, Practice | Morbidity;Newborn | Breastfeeding, Exclusive | Complementary Feeding | Food Security | Integrated Community-based Intervention Package | Birth Preparedness and Complication Readiness Plan | Neonatal Care | Health Care Seeking Behavior | Delivery Care | Postnatal CareEthiopia
-
Aga Khan UniversityBenazir Income Support Programme (BISP); Department of Health, Government of... and other collaboratorsCompleted
-
WorldFishMercy CorpsRecruiting
-
Duke UniversityRecruitingLumbar Spondylosis | Lumbar Spine Degeneration | Lumbar Spine InstabilityUnited States
-
Imperial College LondonImperial College Healthcare NHS TrustEnrolling by invitationBehavioural Science Interventions to Improve Health EquityUnited Kingdom
-
University of California, San DiegoCompleted
-
University of California, San FranciscoNational Institute of Allergy and Infectious Diseases (NIAID)Completed
-
Universidad Peruana Cayetano HerediaNational Institutes of Health (NIH); NGO Via LibreCompleted
-
International Centre for Diarrhoeal Disease Research...Department for International Development, United Kingdom; University of Sydney and other collaboratorsCompleted